These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21159601)

  • 1. Yet another case of haemochromatosis? Ferroportin disease.
    Fowell AJ; Bateman AC; Griffiths WJ; Nash KL
    Gut; 2011 Feb; 60(2):155, 188. PubMed ID: 21159601
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
    Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
    Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic expression of ferroportin disease in a family with the N144H mutation.
    Rosmorduc O; Wendum D; Arrivé L; Elnaggar A; Ennibi K; Hannoun L; Charlotte F; Grangé JD; Poupon R
    Gastroenterol Clin Biol; 2008 Mar; 32(3):321-7. PubMed ID: 18403150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene.
    Liu W; Shimomura S; Imanishi H; Iwamoto Y; Ikeda N; Saito M; Ohno M; Hara N; Yamamoto T; Nakamura H; Hada T
    Intern Med; 2005 Apr; 44(4):285-9. PubMed ID: 15897636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset haemochromatosis caused by a novel combination of TFR2 mutations(p.R396X/c.1538-2 A>G) in a woman of Italian descent.
    Gérolami V; Le Gac G; Mercier L; Nezri M; Bergé-Lefranc JL; Férec C
    Haematologica; 2008 May; 93(5):e45-6. PubMed ID: 18450729
    [No Abstract]   [Full Text] [Related]  

  • 7. G80S-linked ferroportin disease: the first clinical description in a Greek family.
    Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
    Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
    Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
    Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4.
    Chen SR; Yang LQ; Chong YT; Jie YS; Wu YK; Yang J; Lin GL; Li XH
    Intern Med J; 2015 Jun; 45(6):672-6. PubMed ID: 26059880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
    Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E
    Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of familial hemochromatosis].
    Górowska-Pracka D
    Wiad Lek; 1989 Jun; 42(11):754-8. PubMed ID: 2631448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemochromatosis caused by mutations in the iron-regulatory proteins ferroportin and H ferritin.
    Press RD
    Mol Diagn; 2001 Dec; 6(4):347. PubMed ID: 11774199
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic and clinical heterogeneity of ferroportin disease.
    Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
    Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel missense mutation c.470 A>C (p.D157A) in the SLC40A1 gene as a cause of ferroportin disease in a family with hyperferritinaemia.
    Saja K; Bignell P; Robson K; Provan D
    Br J Haematol; 2010 Jun; 149(6):914-6. PubMed ID: 20230395
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel human pathological mutations. Gene symbol: SLC40A1. Disease: haemochromatosis, type 4.
    Relvas L; Claro MT; Bento MC; Ribeiro ML
    Hum Genet; 2009 Apr; 125(3):338. PubMed ID: 19309784
    [No Abstract]   [Full Text] [Related]  

  • 16. [Case of familial idiopathic haemochromatosis].
    Aprosina AG; Mikhailov AA; Mukhun AS
    Ter Arkh; 1968 Feb; 40(2):111-6. PubMed ID: 5675764
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric Ferroportin Disease.
    Galicia-Poblet G; Cid-París E; López-Andrés N; Losada-Pajares A; Jurado-López JC; Moreno-Carralero MI; Morán-Jiménez MJ
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):e205-e207. PubMed ID: 25742196
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited iron export by hepatocytes contributes to hepatic iron-loading in the Hfe knockout mouse.
    Chua AC; Drake SF; Herbison CE; Olynyk JK; Leedman PJ; Trinder D
    J Hepatol; 2006 Jan; 44(1):176-82. PubMed ID: 16271796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroportin disease due to the A77D mutation in Australia.
    Subramaniam VN; Wallace DF; Dixon JL; Fletcher LM; Crawford DH
    Gut; 2005 Jul; 54(7):1048-9. PubMed ID: 15951560
    [No Abstract]   [Full Text] [Related]  

  • 20. Ferroportin (SLC40A1) gene in thalassemic patients of Indian descent.
    Agarwal S; Sankar VH; Tewari D; Pradhan M
    Clin Genet; 2006 Jul; 70(1):86-7. PubMed ID: 16813613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.